Nicolas Chapuis

Plasma vemurafenib exposure and pre-treatment hepatocyte growth factor level are two factors contributing to the early peripheral lymphocytes depletion in BRAF-mutated melanoma patients.

Benoit Blanchet, Nicolas Dupin, F. Goldwasser, 2016, Pharmacological research.

Constitutive phosphoinositide 3-kinase/Akt activation represents a favorable prognostic factor in de novo acute myelogenous leukemia patients.

Philippe Broët, Bruno Lioure, Patrick Mayeux, 2007, Blood.

Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia

Patrick Mayeux, J. Tamburini, C. Lacombe, 2010, Haematologica.